Q Line Biotech Ltd vs Standard Shoe Sole Mould India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Q-Line Biotech Ltd is ₹ 529.55 as of 23 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Standard Shoe Sole & Mould India Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Standard Shoe Sole & Mould India Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The Revenue of Q-Line Biotech Ltd is ₹ 90.03 crore as of Dec '25 .The Revenue of Standard Shoe Sole & Mould India Ltd is ₹ 0 crore as of Dec '25 . The EBITDA of Q-Line Biotech Ltd is ₹ 30.54 crore as of Dec '25 .The EBITDA of Standard Shoe Sole & Mould India Ltd is ₹ 0 crore as of Dec '25 . The Net Profit of Q-Line Biotech Ltd is ₹ 17.38 crore as of Dec '25 .The Net Profit of Standard Shoe Sole & Mould India Ltd is ₹ 0 crore as of Dec '25 . The Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Standard Shoe Sole & Mould India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About Standard Shoe Sole & Mould India Ltd

Standard Shoe Sole and Mould (India) Limited was originally incorporated on 19 July, 1973 as Chemcrown India (Private) Limited with the Registrar of Companies, West Bengal.
Subsequently, the name of the Company was changed to its present name 'Standard Shoe Sole and Mould (India) Limited' and a fresh Certificate of Incorporation reflecting the new name was issued by Registrar of Companies, West Bengal on 14 December, 2001. The Company made its public issue in year 1991 and subsequently got its shares listed at BSE Limited in the same year.
The Company started off as a distributor for the leather chemicals manufactured by Sandoz (India) Ltd. Besides, the Company entered into the manufacture of leather chemicals. The Company had filed a reference on August 02, 1996 with the Board for Industrial and Financial Reconstruction (BIFR) in terms of Section 15 of Sick Industrial Company.

FAQs for the comparison of Q-Line Biotech Ltd and Standard Shoe Sole & Mould India Ltd

Which company has a larger market capitalization, Q-Line Biotech Ltd or Standard Shoe Sole & Mould India Ltd?

Market cap of Q-Line Biotech Ltd is 1,235 Cr while Market cap of Standard Shoe Sole & Mould India Ltd is 6 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and Standard Shoe Sole & Mould India Ltd?

The stock performance of Q-Line Biotech Ltd and Standard Shoe Sole & Mould India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and Standard Shoe Sole & Mould India Ltd?

As of October 25, 2026, the Q-Line Biotech Ltd stock price is INR ₹529.55. On the other hand, Standard Shoe Sole & Mould India Ltd stock price is INR ₹12.88.

How do dividend payouts of Q-Line Biotech Ltd and Standard Shoe Sole & Mould India Ltd compare?

To compare the dividend payouts of Q-Line Biotech Ltd and Standard Shoe Sole & Mould India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.